Improvement of Transition From Hospital to Home for Older Patients in Germany (TIGER)

Transsectoral Intervention Program for Improvement of Geriatric Care in Regensburg

The aim of the transsectoral care project TIGER is the reduction of readmission rates of geriatric patients. This aim shall be achieved by improving the hitherto inadequate care process for geriatric patients in the transition from hospital to home. The program offers substantial support of patients and their informal caregivers in the transition process from hospital to home via so called pathfinders, specialized nurses in geriatrics.The pathfinders effectively intertwine stationary and ambulatory care teams caring for a patient, thereby augmenting and complementing effective hospital release management.

Study Overview

Detailed Description

Especially for older, chronically ill persons, a hospital stay can promote significant losses in functionality, independence and quality of life, and can increase nutrition deficits and the risk for infections, leading to the occurrence of severe gaps in care after hospital release and to an increased risk for readmission rates.

Even if the German government has recognized the necessity of a multiprofessional integrated care program for older, vulnerable patients and has installed a hospital release management program situated in hospitals in 2012, clarifying entitlements to benefits and setting up ambulatory services contacts, this does not yet meet the complex needs of geriatric patients and their informal caregivers.

Internationally, the Transitional Care Model (TCM) has been developed (M. Naylor et al. 1994) to address the deficits in care of older patients in transition between hospital to home. Via a series of defined activities, a disruption of the care supply chain for older patients in this transition process is being avoided.

The TIGER program will address the needs of geriatric patients and their informal caregivers and will support them via structured continuous activities, on the basis of the TCM, by so called pathfinders, nurses specialized in geriatrics. These pathfinders will develop an individual care plan with the patients, their informal caregivers and the hospital physicians already inside the hospital setting and will then develop and improve this further during up to twelve months after the hospital release of the patient. The pathfinders will coordinate the ambulatory care team services and closely involve the primary physicians. The patients and their informal caregivers will be empowered and educated to achieve a stabilization or improvement in functionality, independence, quality of life, coping with disease, nutritional status and wound healing process of the patients.

The aim of the program is that these activities will lead to a reduction of necessary readmission rates of geriatric patients.

Efficacy, practicability, and limitations of the program will be evaluated scientifically and economically and will be analyzed for a possible saving of costs for the health care system.

Study Type

Interventional

Enrollment (Actual)

252

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nürnberg, Germany, 90408
        • Institute for Biomedicine of Aging, University of Erlangen-Nürnberg
    • Bavaria
      • Regensburg, Bavaria, Germany, 93049
        • Hospital of the Order of St.John of God Regensburg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

75 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

will go back home after Hospital stay, AOK Patient, MiniMentalStateExamination MMSE score of at least 22, is living within 50 km range of the hospital

Exclusion Criteria:

palliative status, planned readmission into hospital within next 4 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pathfinder support
Pathfinder support with development of an individual care plan for the intervention patients and their informal caregivers, with the hospital physicians already inside the hospital setting. This will then be developed and improved further during up to twelve months after hospital release with the primary physician. The pathfinders will coordinate the ambulatory care team services and closely involve the primary physicians. The patients and their informal caregivers will be empowered and educated to achieve a stabilization or improvement in functionality, independence, quality of life, coping with disease, nutritional status and wound healing process. In the regular assessments they will be tested for functionality and nutritional parameters, quality of life and stress scores.
A pathfinder will support the patient with structured activities.
No Intervention: Control without pathfinder support
Control patients will not be supported by pathfinders. In regular assessments they will be tested for functionality and nutritional parameters, quality of life and stress scores.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Readmission Rate
Time Frame: up to 12 months
The number of readmissions of a patient into a hospital within up to 15 months (study period for the patient.plus 3 months prior to enrollment).
up to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functionality and mobility - 1
Time Frame: up to 12 months
Timed up and Go in seconds
up to 12 months
Functionality and mobility - 2
Time Frame: up to 12 months
Instrumental activities of daily living (IADL) in scale
up to 12 months
Functionality and mobility - 3
Time Frame: up to 12 months
handgrip strength in kilogramms
up to 12 months
Functionality and mobility - 4
Time Frame: up to 12 months
pedometer activPAL3 micro
up to 12 months
Functionality and mobility - 5
Time Frame: up to 12 months
Short physical performance battery (SPPB) in scale
up to 12 months
Nutritional status
Time Frame: up to 12 months
measured bei Mini Nutritional Assessment (MNA)
up to 12 months
Health-related quality of life
Time Frame: up to 12 months
Measured by Short-Form-Health Survey (SF-12) questionnaire in scale
up to 12 months
Depression
Time Frame: up to 12 months
Measured by Geriatric Depression Scale (GDS) in scale
up to 12 months
Cognitive Status - 1
Time Frame: up to 12 months
Measured by Mini-Mental State Examination (MMSE) in scale
up to 12 months
Cognitive Status - 2
Time Frame: up to 12 months
Trail Making Test A&B in seconds
up to 12 months
Burden of informal caregivers - 1
Time Frame: up to 12 months
Measured by Zarith-questionnaires in scale
up to 12 months
Burden of informal caregivers - 2
Time Frame: up to 12 months
Perceived Stress Questionnaire (PSQ)-questionnaires in scale
up to 12 months
Transfers into nursing homes
Time Frame: Up to 12 months
Comparison between intervention and control group. Data made available by cooperating partner Allgemeine Ortskrankenkasse (AOK) sickness fund in percent
Up to 12 months
Care situation, care supply and quality of care at home
Time Frame: up to 12 months
Measured by Neues BegutAchtungsinstrument (NBA, Buscher, Wingenfeld & Schaeffer, 2011) as scale
up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 25, 2018

Primary Completion (Actual)

June 30, 2020

Study Completion (Actual)

February 28, 2021

Study Registration Dates

First Submitted

April 17, 2018

First Submitted That Met QC Criteria

April 27, 2018

First Posted (Actual)

May 1, 2018

Study Record Updates

Last Update Posted (Actual)

March 3, 2021

Last Update Submitted That Met QC Criteria

March 2, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • IBA-2018-TIGER

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The final anonymized trial data set will be available to the TIGER consortium. After completion of evaluation and dissemination by the TIGER-consortium, the goal is that an anonymized data set will be made available to interested Researchers upon reasonable request, being deposited in a repository of the University.

During finalization of the study a detailed data sharing plan will be developed and introduced into this trial registry.

IPD Sharing Time Frame

The repository of the data set is under construction with the University.

IPD Sharing Access Criteria

Anonymized data set will be available to interested Researchers upon reasonable request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Geriatric Patients in the Transition From Hospital to Home

Clinical Trials on Pathfinder support

3
Subscribe